GeoVax Labs, Inc. (GOVX) vs iSpecimen Inc. (ISPC)
A side-by-side comparison of GeoVax Labs, Inc. and iSpecimen Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GOVX
GeoVax Labs, Inc.
$0.28HealthcareDelayed quote: Oct 6, 2026, 1:29 PM EDT
ISPC
iSpecimen Inc.
$1.09HealthcareDelayed quote: Oct 6, 2026, 1:28 PM EDT
Not enough overlapping price history to compare GOVX and ISPC.
GOVX vs ISPC: by the numbers
- •ISPC is the larger company ($3M vs $2M market cap).
- •Both run net losses; GOVX's is the smaller (-862.34% vs -2449.04% net margin).
Metrics side by side
Valuation
| Metric | GOVX | ISPC |
|---|---|---|
| P/S ratio | N/A | 5.86 |
| P/B ratio | 1.18 | 1.57 |
Profitability
| Metric | GOVX | ISPC |
|---|---|---|
| Gross margin | -628.02% | 1.25% |
| Operating margin | -869.34% | -465.42% |
| Net margin | -862.34% | -2449.04% |
| ROE | -1160.10% | -657.69% |
| ROIC | -985.20% | -476.39% |
Growth (annualized)
| Metric | GOVX | ISPC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -46.70% |
| Total return CAGR (5Y) | N/A | -81.14% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.